Numerical and structural chromosomal abnormalities are the hallmarks of cancer. Whereas the structural chromosome aberrations got more substantial attention for cancer risk assessment in a healthy population, the role of aneuploidy is much less understood in this respect. We analysed the frequency of numerical (and structural) aberrations in peripheral blood lymphocytes of 2145 healthy individuals between 1989 and 2010, taking into account different biological-and exposureconditions. We also studied to what extent chromosome gains or losses may predict the probability of cancer. The average frequency of all aneuploid cells was 1.78 ± 0.06% in the entire study population, which increased linearly with age. Gender and smoking did not influence the values, however, occupational exposures did. The highest frequency of aneuploidy was found in chemical industryworkers (1.89 ± 0.05%) compared with the lowest value of medical radiation workers (1.44 ± 0.10%), respectively. No correlation was found between numerical and structural chromosomal aberrations. Cancer incidence followed for 1−23 years after the chromosome analysis showed a 1.26-fold relative risk (confidence interval: 1.02-1.58; P = 0.04) for those with higher frequency of aneuploid cells (1.82% vs. 1.44% in controls). Hypodiploidy had higher impact on the cancer risk than hyperdiploidy (1.72% vs. 0.10%). Our findings on the frequency of numerical aberrations in a healthy cohort represent the largest cytogenetic database from one laboratory with an unchanged mechanistic scoring method during a 30-year period, and provide basic information not only for genotoxicological studies but also confirm the association between numerical aberrations and cancer risk.
Introduction
Genetic instability, which includes both numerical and structural chromosomal abnormalities, is a hallmark of cancer. Structural chromosome aberrations may be induced via DNA breakage, and their survival depends on the fate of DNA breaks. Cancer risk can be estimated on the basis of biomonitoring of populations with structural aberrations emerging in the first cell cycle. Numerical aberrations refer to changes in normal chromosome number which occur due to abnormal chromosome segregation, i.e. they arrive from completely different mechanisms than structural aberrations, occurring either spontaneously or due to the action of different aneugens (1) . Therefore, chromosome instability, and thus, genetic instability in this respect should be examined separately.
Whereas the structural chromosome aberrations received substantial attention in the assessment of cancer risk, the role of aneuploidy is much less understood. Despite a century-old theory about the connection between aneuploidy and cancer, it is still not clear whether the aneuploidy is the cause or the consequence of cancer (2) (3) (4) (5) (6) .
Recently in a large pooled cohort study involving more than 22 000 persons from 11 European countries, we demonstrated clear relationship between rates of structural chromosomal aberrations and cancer risk (7, 8) .
However, the linkage between numerical chromosomal abnormalities and cancer incidence was not studied, because information about aneuploidy was available only for a small part of participating countries. The data on spontaneous frequency of numerical chromosomal aberrations were available for quite a large number of Hungarian healthy subjects (in this study 2145 persons), and the method and scoring criteria did not undergo any changes during the last 30 years. Therefore, we were able to evaluate the impact of different biological and exposure conditions on aneuploidy and risk of cancer in this study.
Our main question was, to what extent chromosome gains or losses, i.e. spontaneous frequency of hyper-or hypodiploid cells in peripheral blood lymphocytes of healthy persons may predict the probability of cancer within a 1-to 23-year period following the chromosome analysis.
Materials and methods

Selection of individuals
Each person out of the cohort of 2145 healthy individuals was asked to complete a questionnaire designed to provide relevant details of his/her biological and exposure conditions. The study was approved by the Local Ethical Committee of National Institute of Oncology (Grant: EU -5th Framework, QLK4-CT-2002-02831  and 0506/2003) , and was conducted following the principles of the Helsinki Declaration and ICPEMS considerations (9) . All subjects were informed about the aim of the study and gave their written consent to participate in genotoxicological population screening. Present cytogenetic data base was collected and analysed between 1989 and 2010, and the results were linked to the database of National Cancer Registry (NCR) between 1990 and 2012. Cancers were classified according to ICD-10. Persons with non-melanoma skin cancers were excluded from the study as it was also done in the original database (7, 8) . When a person was tested more than once, only the first examination was considered for frequency classification.
Selection criteria
1. All individuals had valid demographic data and were at least 18 years old, without a previous cancer diagnosis or treatment at the time of cytogenetic test. 2. They had not undergone diagnostic radio-imaging that exposed the large bones or lymph nodes. 3. Persons with chronic diseases, e.g. bronchial asthma, progressive polyarthritis or other autoimmune diseases requiring continuous drug treatment were excluded. 4. Persons that had viral or bacterial infections and antibiotic therapy within 6 months prior to sampling were excluded. 5. Volunteers who smoked regularly for >1 year before blood sampling were considered as smokers. 6. The cytogenetic analysis was based on a minimum of 100 metaphases.
Controls (966 persons)
Controls were healthy volunteers including new employment recruits, clerks, students, soldiers, salesmen, etc. living or working in the capital city Budapest, and rural communities (10, 11).
Exposed (1179 persons)
Information on occupational exposure at the time of the chromosomal aberration test was available for 1179 subjects, but the details varied during the sample collection, therefore, a special classification scheme was developed on the basis of the following categories: Persons were exposed at workplaces for a minimum of 1 year before the blood sample collection.
Follow-up
The follow-up period for cancer incidence was defined as 1 year after the date of the first cytogenetic test until the date of cancer diagnosis, or the end of the follow-up. Demographic data of persons are presented in Table 1 .
Blood sampling, culturing and chromosome analysis
Venous blood sample was obtained by venipuncture into Li-heparinized vacutainers. Samples were stored at 4°C for a maximum of 24 h, until the start of incubation of the whole blood for 48 h. The culturing and the chromosome preparation were carried out by standardised methods routinely applied in our laboratory (12) . Chromosome analysis was performed in the first cell division, and a minimum of 100 metaphases per person were scored. All aberration types were recorded: aneuploid cells, chromatid and -test and regression analysis were used for statistical analyses, and the P value of <0.05 was considered as the limit of significance. GraphPad InStat 3 and GraphPad Prism 5 software packages were used for calculations and data presentation (13) .
Results
We think that it is important to note right from the outset of the interpretation of our data that structural-or numerical aberration we identified did not exceed 1% interscorer variability during the study.
Males and females were equally represented in the cohort, and 36.8% of the donors were smokers. According to the percentage of participants, unexposed controls (45%) and chemical-industry workers (40%) accounted for the largest groups (Table 1) .
In Table 2 , we summarised the mean percents of cells with aneuploidy, and structural aberrations according to biological (gender) and exposure conditions (smoking, occupational exposure). The average frequency of aneuploidy for the whole cohort was 1.78 ± 0.06%. It represents a mean value of the spontaneous frequency of numerical aberrations characterising a healthy Hungarian population. In unexposed controls the frequency of aneuploidy was not influenced by gender. However, occupationally exposed persons working in the chemical industry had the highest yield of aneuploid cells (1.89 ± 0.05%). On the other hand, the staff working in radiation exposure area had the lowest frequency of numerical aberrations (1.44 ± 0.10%). Smoking status had no effect on aneuploidy.
Since genetic-and chromosome instability are highly interrelated, in order to estimate the level of chromosome instability in a whole, the sensitivity of both biomarkers, i.e. aneuploidy and/or structural aberrations were compared in this respect. The average frequency of cells containing structural aberrations was 1.58 ± 0.04% in the whole cohort but, surprisingly, it reached the highest value in occupationally unexposed control males (1.82 ± 0.10%). In addition, smokers also had elevated yield of aberrant cells (1.78 ± 0.06%) which could be due to increased number of chromatid type aberrations in both cases. Results of our studies also show that in different subgroups of Hungarian cohort there is no association between numerical and structural aberrations. Effect of the age on the aneuploidy was also investigated in a 5-year grouping of persons (Figure 1 ) regardless other confounding variables. Numerical aberrations were grown nearly linearly with the age of persons (r 2 = 0.81; and the slope of the curve was m = 0.01). Therefore, it seems that increase in age is the most meaningful factor in the elevation of numerical aberrations.
Over 55 years of age unexposed controls (105 subjects) and occupationally exposed persons (63 persons) had the highest elevation rate of aneuploidy (2.06 ± 0.16% vs. 2.29 ± 0.25%) in contrast to younger than 35 year-old subjects (1.55 ± 0.07% vs. 1.72 ± 0.07%, respectively). Between 35 and 55 years of age persons belonging to unexposed and exposed groups had no significant differences for aneuploidy (1.78 ± 0.07% vs. 1.84 ± 0.06%). Not only determination of spontaneous level of aneuploidy of a healthy population was of interest for us, but also conditions that might later alter the dosage of many regulatory and structural gene products, that could directly or indirectly increase genetic instability. Therefore, we also studied whether hyper-or hypodiploidy i.e. gain or loss of chromosomes are more characteristic for the proportion of numerical aberrations in the cohort. No aneuploid cells were found in 455 persons (22%), and 1-11% of aneuploid cells occurred in 1690 subjects (78%) ( Table 3) . We observed that 97 people developed cancer during the followup period of 1-23 years, and among them 21 persons (21.6%) had no aneuploid cells, while 76 individuals (78%) had them. It seems that the proportion of aneuploid and normal diploid cells is equal in cancer-free persons, and in those developing cancer during the follow-up period. The average of aneuploid cells in the initial cohort was 1.78%. The hypodiploids with 45 chromosomes were found with frequency of 1.04%, while those with 44-chromosomes with frequency of 0.58%.
Ninety-seven out of 2145 persons developed cancer, which constituted 4.5% of the study population. There was no difference between males and females (4.3% of the men and 4.8% of the women developed cancer).
When 97 cancer-free controls were matched in smoking habits, age-and exposure conditions to individuals developing cancer during the follow-up period, we found higher aneuploid cell frequency in cancer patients (1.82%) than in the matched controls (1.44%) ( Table 4 ). The relative risk shows a 1.26-fold increase (confidence interval: 1.02-1.58; P = 0.041), i.e. an indication that aneuploidy has really an impact on cancer risk. Hypodiploidy constitutes a greater risk factor for cancer incidence with the occurrence of both 44 (0.70% vs. 0.48%) and 45 chromosomes (1.02% vs. 0.79%) when compared with matched controls, and/ or with hyperploid cells (0.10% vs. 0.16%). The relationship between cancer risk and numerical aberrations indicates an epidemiological confirmation of the role of aneuploidy in the prediction of cancer, similarly to the role of structural chromosome aberrations.
Different cancer types were developed in 97 patients, but they could not be associated with any specific tumor site. Colorectal cancer occurred most frequently (n = 10), followed by lung and breast cancer (n = 9), malignant melanoma (n = 8), and bladder cancer (n = 7). Stomach-, thyroid cancer, leukemias and non-Hodgkin lymphoma occurred in four persons each, while other tumour types were noted only 1-2 cases. We found that only those persons developed any type of cancer within 1-12 years from the time elapsed between chromosome analysis and cancer morbidity who had at least 2 or more percent of aneuploid cells.
Discussion
Mechanistic evaluation, i.e. metaphase-based cytogenetics regarding the counting of spontaneous aneuploidy and structural aberrations has become a challenge long before molecular cytogenetic approaches in cancer risk assessment. It is obvious that this method of detection is very much time-consuming, particularly in the case of the scoring of numerical aberrations, therefore only very few data are available for the spontaneous level of aneuploid cells, and their role in cancer risk estimation (14) (15) (16) . We consider that the suggestion of Carrano and Natarajan are still valid, i.e. 'Human specimen from exposed and control populations are precious resource to the scientific community. Whenever possible, these specimens should be made available to interested collaborators for the concurrant or subsequent application of other genetic endpoints relevant to the suspected exposure' (9) .
Thus, we also underline that all data altering the spontaneous level of aneuploidy in a healthy population require the knowledge of a large number of 'everyday' confounders too. Since methods of different molecular techniques such as DNA probe-hybridisation, interphase FISH methods, microarray techniques or micronucleus analysis (17) provide still not enough information about the relationship between spontaneous rate of aneuploidy and cancer incidence. Our data on a large number of healthy subjects may serve as a fundamental basis for a good orientation in this question, despite the fact that mechanistic scoring of numerical chromosomal aberrations was suggested to be not suitable for the estimation of any risks (17) (18) (19) . In connection with this statement, we would like to draw the attention to the fact that, for a very long time, the testing strategies have not even included a specific requirement regarding the determination of the potential of chemicals for induce aneuploidy in vivo or in vitro (20) . Since aneuploidy is a major contributor to cancer initiation and progression, it is very important that any increase in its frequency due to chemical or other exposures should be recognised and controlled under in vivo conditions and at population level too (21) .
In the course of the examination of any causes and factors inducing aneuploidy, we have to identify to what extent various biological (sex, age) and exposure factors (e.g. smoking, occupational exposures) have genetic overload on somatic cells in a healthy reference population.
We started collecting our data on chromosomal aberrations extensively in the 80s, in order to identify the role of gender, age, smoking habits, occupational exposures and affiliation to settlements. Formerly, we found that the frequency of aneuploid cells was mostly influenced by age >40 years and smoking habits, but the place of residences did not play any role for numerical aberration-formation (1.83 ± 0.08% for urban, and 1.78 ± 0.07% for rural inhabitants) of 1414 individuals (11, 22) .
In our previous study, we only paid attention to the base-line level of aneuploids in a whole. Hypo-or hyperdiploid cells were scored but not assigned to cancer-incidence statistics. The mean frequency of all aneuploid cells was 1.83 ± 0.05% for 1414 persons. In the present study, the average of aneuploid frequency is a bit lower (1.78 ± 0.06%) for 2415 healthy persons studied between 1989 and 2010. To our knowledge this is the largest cytogenetic database (3829 persons in total) which shows that a mean value of aneuploidy is constantly around 2%.
Different authors from different laboratories may reveal substantial discrepancies regarding the baseline level of aneuploidy. For example depending on the methods applied, molecular technologies show much higher frequencies than mechanistic scoring of aneuploid cells, particularly FISH versus metaphase spreading (23) . Our data are rather constant during this long period of time. One of the advantages of this work is the use of a harmonised method for a large number of individuals collected in the same laboratory during a 30-year period. Since these circumstances allowed us to reduce interscorer variability for <1%, we are convinced that the use of the mechanistic scoring method is fully permissible also for the estimation of cancer risk.
Formerly, Bender et al. studied a large healthy human population including 613 blood samples originated from 493 persons, and found 6.17% frequency of aneuploids with 2n = 45 chromosomes, and 0.17% for 2n = 47 chromosomes, respectively. The hypoploidy was three-fold, while hyperploidy was very similar to values scored in our study (24) .
In a small study, it was reported that 8% of metaphases showed aneuploidy from 32 women compared to 4% of metaphases from 35 men, and in PHA culture of lymphocytes the incidence of aneuploidy was positively age-related in both sexes (25) .
In our cohort, we found no effect of gender on aneuploid frequency, but also observed its increase with age of the persons. Neurath et al. (26) examined 139 individuals (between the ages of 2 weeks and 93 years) and also found that aneuploidy increased with age, however, Sandberg et al. (27) reported no significant association between the age and the number of cells with hypo-or hyperdiploidy. Wojda et al. (28) described a positive correlation of the chromosome-specific loss with age for the X chromosome in women. Later, molecular cytogenetic studies of metaphases, interphase nuclei, and micronuclei in cells from elderly people, also showed an increase in aneuploidy (29, 30) .
We suppose that exploitation of the knowledge gained from our and other studies in respect to the role of the age in aneuploidy might allow the further screening for identification of 'at risk' persons, not only for cancer risk assessment, but also for other age-related diseases.
Smoking had no effect on aneuploidy in our cases. Some studies showed that smoking did increase, while others that it did not increase the frequencies of structural CAs, but increased the frequency of hyperploidy (31) . No clear trend has emerged up to now in this respect.
Occupational exposure significantly affected numerical aberrations, which may be attributable to substances (among others to benzene and toluene) produced by workers in chemical industry. Zhang et al. (32) investigated aneuploidy involving all the 24 chromosomes with FISH method in benzene-exposed and nonexposed individuals. Aneuploidy was found to be significantly higher for certain chromosomes, and the frequency showed dose-dependence.
In present cohort study the numerical aberrations had the lowest frequency among people working with radiation sources. Probably, ionising radiation is not an aneugenic factor, especially if people obey working safety rules.
In our study, the presence of 45 chromosomes was the most common in each age group followed by 44 chromosomes, and 47 chromosomes had the lowest ratio. This result is similar to that found by Neurath and Enslein (33) .
In order to validate any conclusions gained from this study, we think that the importance of these examinations is the following: we investigated healthy controls and exposed persons under the same laboratory conditions, and standard procedures. We determined a rather constant frequency of spontaneous rate of aneuploidy characterising a large number of healthy persons. It seems that the average frequency of aneuploidy constitutes 1.78 ± 0.06%. Moreover, cancer occurrence is really associated with aneuploidy and mostly with hypodiploidy, and thus, this method can be suggested not only as an additional biomarker for the evaluation of genotoxic exposures, but also for cancer risk assessment. 
